Solstice Biologics Garners $18,000,000 Series A Round

  • Feed Type
  • Date
    1/5/2013
  • Company Name
    Solstice Biologics
  • Mailing Address
    1700 Owens Street San Francisco, CA 94158
  • Company Description
    Solstice Biologics is a private company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. The company is developing small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $18,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    venBio
  • Venture Investor
    Aeris Capital AG

By posting a comment, you agree to our terms and conditions.